Testing BRCA1 Variants Identifies Differences in Breast Cancer Risk

Researchers at the Francis Crick Institute have tested thousands of BRCA1 gene mutations in mammary gland cells to determine which variants increase breast cancer risk. This research could improve the interpretation of genetic test results in the future, aiding in better risk assessment and personalized medicine.

Originally published by gnews